InternationalUSRemember you can easily switch between MIP US and MIP International at any time

European Commission claims pharma competition success

Legal Media Group


The proportion of problematic patent settlements in the pharmaceutical industry has fallen, even though the number of settlements has grown, according to the European Commission

In a statement published on January 31, the Commission said that its third annual survey had found that 11% of antitrust settlements were potentially problematic from an antitrust point of view, compared to 21% when the pharmaceutical sector enquiry was conducted in 2008 to 2009.

That came as the total number of settlements reached 120 in 2011,...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Why the PTAB could yet affect VirnetX's $626 million award in patent win over Apple https://t.co/RepYKTZn9K ($/trl) https://t.co/PrgbA04tKy

Feb 5 2016 05:36 ·  reply ·  retweet ·  favourite
ManagingIP profile

Looks like the Jan 1900 TM application date may be inaccurate! #NUTELLAgate https://t.co/NA3mKC7FxP

Feb 5 2016 04:43 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @WithersRogers: Excited for "The Big Game"? The NFL's hyper-vigilant #trademark enforcement leaves companies fearing infringement https:…

Feb 5 2016 04:42 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


February 2016

A new era for EU trade marks

Are you ready for the fundamental changes coming to trade mark law and practice in Europe? Over the next four pages, we provide pointers for steps you need to consider – and when. By James Nurton



Most read articles

Supplements